Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | SEIDENBERG BETH C | Dec 18, 2025 | Buy | $1M | 133,333 |
| 10% Owner | Westlake BioPartners Opportunity Fund I, L.P. | Dec 18, 2025 | Buy | $1M | 133,333 |
| Chief Technology Officer | Walker Karen Marie | Dec 15, 2025 | Sell | $292.78K | 23,998 |
| Insider | Northpond Ventures III GP, LLC | Feb 12, 2024 | Buy | $9.9M | 450,000 |
| 10% Owner | Bain Capital Life Sciences Investors, LLC | Feb 12, 2024 | Buy | $9.9M | 450,000 |
| 10% Owner | GILEAD SCIENCES, INC. | Feb 12, 2024 | Buy | $20.02M | 910,000 |
| 10% Owner | Vida Ventures, LLC | Feb 12, 2024 | Buy | $5.56M | 252,553 |
| 10% Owner | Vida Ventures, LLC | Feb 12, 2024 | Buy | $12.83K | 583 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.